A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve. But ...

Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a specific type of immune cell may contribute to the persistence of HIV ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

The National Institutes of Health placed a big bet on Oregon scientist Jonah Sacha this week, awarding Sacha and his colleagues an $8.4 million, five-year grant for their work developing a cure for ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

HIV spreads through direct contact with the bodily fluids of infected individuals. Once individuals are infected, HIV particles target our T cells, a type of white blood cell. Healthy T cells identify ...